Proteinases involved in matrix turnover during cartilage and bone breakdown

被引:126
作者
Cawston, Tim E. [1 ]
Young, David A. [1 ]
机构
[1] Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
基金
英国惠康基金;
关键词
Cartilage; Collagen; Extracellular matrix; Metalloproteinase; Arthritis; HISTONE-DEACETYLASE INHIBITORS; NECROSIS-FACTOR-ALPHA; COLLAGEN-INDUCED ARTHRITIS; HUMAN ARTICULAR-CARTILAGE; METALLOPROTEINASE GENE-EXPRESSION; HUMAN OSTEOARTHRITIC CARTILAGE; PROGRESSIVE JOINT DESTRUCTION; AGGRECAN-DEGRADING ACTIVITY; HUMAN RHEUMATOID-ARTHRITIS; BOVINE NASAL CARTILAGE;
D O I
10.1007/s00441-009-0887-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The joint is a discrete unit that consists of cartilage, bone, tendon and ligaments. These tissues are all composed of an extracellular matrix made of collagens, proteoglycans and specialised glycoproteins that are actively synthesised, precisely assembled and subsequently degraded by the resident connective tissue cells. A balance is maintained between matrix synthesis and degradation in healthy adult tissues. Different classes of proteinases play a part in connective tissue turnover in which active proteinases can cleave matrix protein during resorption, although the proteinase that predominates varies between different tissues and diseases. The metalloproteinases are potent enzymes that, once activated, degrade connective tissue and are inhibited by tissue inhibitors of metalloproteinases (TIMPs); the balance between active matrix metalloproteinases and TIMPs determines, in many tissues, the extent of extracellular matrix degradation. The serine proteinases are involved in the initiation of activation cascades and some, such as elastase, can directly degrade the matrix. Cysteine proteinases are responsible for the breakdown of collagen in bone following the removal of the osteoid layer and the attachment of osteoclasts to the exposed bone surface. Various growth factors increase the synthesis of matrix and proteinase inhibitors, whereas cytokines ( alone or in combination) can inhibit matrix synthesis and stimulate proteinase production and matrix destruction.
引用
收藏
页码:221 / 235
页数:15
相关论文
共 169 条
[1]   Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis [J].
Ahrens, D ;
Koch, AE ;
Pope, RM ;
SteinPicarella, M ;
Niedbala, MJ .
ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1576-1587
[2]   MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[3]   Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase [J].
Arner, EC ;
Hughes, CE ;
Decicco, CP ;
Caterson, B ;
Tortorella, MD .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 (03) :214-228
[4]  
Barrett A. J., 2012, Handbook of proteolytic enzymes, V1
[5]   Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs) [J].
Becherer, JD ;
Blobel, CP .
CELL SURFACE PROTEASES, 2003, 54 :101-123
[6]   An aggrecan-degrading activity associated with chondrocyte membranes [J].
Billington, CJ ;
Clark, IM ;
Cawston, TE .
BIOCHEMICAL JOURNAL, 1998, 336 :207-212
[7]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[8]   Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? [J].
Blanchard, F ;
Chipoy, C .
DRUG DISCOVERY TODAY, 2005, 10 (03) :197-204
[9]   Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin [J].
Boldt, HB ;
Overgaard, MT ;
Laursen, LS ;
Weyer, K ;
Sottrup-Jensen, L ;
Oxvig, C .
BIOCHEMICAL JOURNAL, 2001, 358 (02) :359-367
[10]   Matrix metalloprotease inhibitors: design from structure [J].
Borkakoti, N .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :17-20